T1	Intervention 1439 1531	randomly assigned to receive oral treatment with amlodipine camsylate or amlodipine besylate
T2	Intervention 1533 1602	For the first 4 weeks, patients received amlodipine 5 mg QD (morning)
T3	Intervention 1604 1794	After 4 weeks, if either blood pressure was > or =140/ > or =90 mm Hg or SiDBP had not decreased by > or =10 mm Hg from baseline, the dose of amlodipine was increased to 10 mg QD for 4 weeks
T4	Intervention 1796 2015	Trough blood pressure and heart rate were measured in duplicate with the patient in the sitting position at each clinic visit (baseline [week 0] and weeks 4 and 8 of treatment); mean values were calculated and recorded.
T5	Intervention 2016 2151	At weeks 4 and 8, tolerability was assessed using history taking and laboratory analysis, and compliance was assessed using pill counts
